As per our new research report “US Diagnostic Market Outlook 2014”, the demand for patient monitoring equipment in the US is affected by a complex mix of economic, demographic, and diagnostic industry advancements. Various factors, such as aging population with an expanding number of chronic conditions, many of which can be improved or controlled by regular monitoring, are driving the growth of the patient monitoring systems in the US diagnostics industry. As a result, the demand for patient monitoring system in the US is anticipated to grow at a CAGR of around 7% during 2009-2014.
Our study indicates that, key determinants of epidemiological patterns, population, and age distribution trends shape demand levels and growth prospects for patient monitoring systems. Growth in the middle-aged and elderly population will lead to an expanding prevalence of cardiovascular, diabetic, and other chronic conditions, often managed through continuous, frequent or periodic monitoring. However, trends in health insurance coverage and related reimbursement policies will have a stronger impact on the number of patients actually monitored.
Besides, we have done thorough research and prudent analysis of the US diagnostics industry and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that, the US IVD industry is already in a pivotal position to secure a significant share in the healthcare industry. The main reason for bright prospects are prevalence of several chronic and infectious diseases, emergence of technologies in molecular diagnostics, point-of-care testing, and spreading of awareness among health professionals and patients.
As per our research on the industry, the molecular diagnostic tests will be a major growth driver of the industry in near future due to the increasing consumer awareness about health concerns. The demand for highly technological innovative tests will increase as they are capable of providing more precise results.
The report “US Diagnostic Market Outlook 2014” evaluates the US diagnostic market potentials and identifies future growth opportunities. The report provides extensive research and analysis on the current market trends and future forecasts on all prominent diagnostic techniques including POCT, clinical chemistry, immunoassays, blood testing, and molecular diagnostics. Further, the report facilitates information/statistics on the market developments in laboratory applications and disease indications. Projections made on market future scenario will help clients to take informed and proactive business decisions in the fast growing US diagnostic market.
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.